Searches both title and fulltext content
Takes you to the requested AOP
Clear Search Terms Clears search terms and filters

Showing 301 to 325 of 476 AOPs

Clear Table Filters
ID Title Point of Contact License MIE AO OECD Status OECD Project
358 Chitinase inhibition leading to mortality Evgeniia Kazymova BY-SA 1806: Inhibition, Chitinase 350: Increase, Mortality Under Development 1.94
359 Chitobiase inhibition leading to mortality Cataia Ives BY-SA 1807: Inhibition, Chitobiase 350: Increase, Mortality Under Development 1.94
360 Chitin synthase 1 inhibition leading to mortality Brendan Ferreri-Hanberry BY-SA 1522: Inhibition, Chitin synthase 1 350: Increase, Mortality WPHA/WNT Endorsed 1.94
361 Sulfonylureareceptor binding leading to mortality Arthur Author BY-SA 1525: Increase, Sulfonylurea receptor binding 350: Increase, Mortality Under Development 1.94
362 Immune mediated hepatitis Agnes Aggy BY-SA 1814: benzoquinone imine and acylglucuronide metabolites 1820: Immune mediated hepatitis
363 Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure Allie Always BY-SA 279: Thyroperoxidase, Inhibition Under Review 1.35
364 Thyroperoxidase inhibition leading to altered visual function via decreased eye size Evgeniia Kazymova BY-SA 279: Thyroperoxidase, Inhibition Under Development 1.35
365 Thyroperoxidase inhibition leading to altered visual function via altered photoreceptor patterning Cataia Ives BY-SA 279: Thyroperoxidase, Inhibition Under Development 1.35
366 Competitive binding to thyroid hormone carrier protein transthyretin (TTR) leading to altered amphibian metamorphosis Brendan Ferreri-Hanberry BY-SA 957: Binding, Transthyretin in serum 1101: Altered, Amphibian metamorphosis
367 Competitive binding to thyroid hormone carrier protein thyroid binding globulin (TBG) leading to altered amphibian metamorphosis Arthur Author BY-SA 1831: Binding, Thyroid binding globulin in serum 1101: Altered, Amphibian metamorphosis
368 Cytochrome oxidase inhibition leading to olfactory nasal lesions Agnes Aggy BY-SA 1840: Inhibition, cytochrome oxidase 872: Increase, Site of Contact Nasal Tumors
369 Photosystem II antagonism leading to growth inhibition via oxidative damage Allie Always BY-SA None None
370 Photosystem II antagonism leading to growth inhibition via suppression of photosynthesis Evgeniia Kazymova BY-SA None None
371 Photosystem II antagonism leading to growth inhibition via dysregulation of growth hormone Cataia Ives BY-SA None None
372 Androgen receptor antagonism leading to testicular cancer Brendan Ferreri-Hanberry BY-SA 26: Antagonism, Androgen receptor 1839: Testicular Cancer
373 Mitochondrial dysfunction to metabolic diseases Arthur Author BY-SA None None
374 Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis Agnes Aggy BY-SA 1739: Binding to ACE2 1841: Encephalitis Under Development 1.96
375 test AOP Allie Always BY-SA None None
376 Androgen receptor agonism leading to male-biased sex ratio Evgeniia Kazymova BY-SA 25: Agonism, Androgen receptor 360: Decrease, Population growth rate WPHA/WNT Endorsed 1.12
377 Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS) Cataia Ives BY-SA 1842: Prolonged TLR9 activation
378 Dysregulated underperforming Toll Like Receptors (TLRs) leading to high pathogen load Brendan Ferreri-Hanberry BY-SA 1848: Toll Like Receptor (TLR) Dysregulation None
379 Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation Arthur Author BY-SA 1739: Binding to ACE2 1846: Thrombosis and Disseminated Intravascular Coagulation Under Development 1.96
381 Binding of viral S-glycoprotein to ACE2 receptor leading to dysgeusia Agnes Aggy BY-SA 1739: Binding to ACE2 1850: dysgeusia Under Development 1.96
382 Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis Allie Always BY-SA 1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R) 1276: Lung fibrosis Under Development 1.96
383 Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis Evgeniia Kazymova BY-SA 1740: Induced dysregulation of ACE2 344: N/A, Liver fibrosis Under Development 1.96